Skip to:

About the Interim Dean

Ron Brookmeyer, PhD—an internationally renowned researcher, award-winning teaching and elected member of the National Academy of Medicine—began his term as interim dean of the UCLA Fielding School of Public Health in November 2018.

Brookmeyer, who joined UCLA in 2010 as a professor of biostatistics, uses the tools of the statistical, informational and mathematical sciences to address global public health problems. During a span of more than three decades, he has developed statistical methods to help identify and address the major global health challenges of our times. Among Brookmeyer’s many accomplishments, he earned worldwide recognition for predicting the magnitude of the impending HIV/AIDS epidemic with work beginning in the mid-1980s, and, through widely cited studies, he has called attention to the looming Alzheimer’s disease epidemic.

After completing his MS and PhD in statistics at the University of Wisconsin, Brookmeyer joined the faculty of the Johns Hopkins Bloomberg School of Public Health in 1981. He served as the director of Johns Hopkins school-wide interdepartmental master of public health program, which included more than 700 students and 200 faculty advisors and an online program. He has also consistently been recognized for exceptional teaching, during his tenure at both the Bloomberg School of Public Health and at the Fielding School of Public Health.

Brookmeyer’s numerous honors include being named a fellow of the American Association for the Advancement of Science and a recipient of the American Public Health Association’s Mortimer Spiegelman Gold Medal in health statistics, the American Statistical Association’s Nathan Mantel Lifetime Achievement Award and the Karl E. Peace Award for outstanding statistical contributions for the betterment of society. He has served on several scientific panels, editorial boards and advisory boards—including the external advisory board of the Mayo Clinic Study of Aging and the World Health Organization’s working group: Blueprint for Vaccine Trial Design in Public Health Emergencies—and is currently a member of the board of reviewing editors of Science magazine.